145720
05/03/2024
St Clara's Rehab & Senior Care
1450 Castle Manor Drive Lincoln, IL 62656
F 0623
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Many
Provide timely notification to the resident, and if applicable to the resident representative and ombudsman, before transfer or discharge, including appeal rights.
Based on interview and record review, the facility failed to notify in writing, and maintain a copy in the medical record notification to the Ombudsman of residents that were reviewed for notices before transfers. This failure has the potential to affect all 94 Residents residing in the Facility.
Findings include: admission and Discharge/Transfer log reviewed with multiple residents discharged /transferred. On 5/1/24 at 8:41 AM, V1 Assistant Administrator was unable to provide any documentation the Ombudsman was notified of resident transfers. We notify the Ombudsman of resident admits and discharges out of the building but not if they transfer to the hospital. Facility Application for Medicare/Medicaid, dated 5/1/24, documents 94 Residents reside in the Facility.
Page 1 of 4
145720
145720
05/03/2024
St Clara's Rehab & Senior Care
1450 Castle Manor Drive Lincoln, IL 62656
F 0686
Provide appropriate pressure ulcer care and prevent new ulcers from developing.
Level of Harm - Minimal harm or potential for actual harm
Based on observation and interview, the facility failed to ensure pressure ulcer wound treatment was completed in a manner to prevent potential cross contamination of the wound for one resident (R55) of five residents reviewed for pressure wounds, in a total sample of 39.
Residents Affected - Few
FINDINGS INCLUDE: On 05/01/24, at 11:00 a.m., V6/Licensed Practical Nurse provided wound care for R55's stage II (dime-sized/no drainage) coccyx area pressure wound. V6 turned R55 on R55's left side; opened R55's incontinence brief and exposed R55's wound/no dressing noted on wound; washed the wound area with spray cleanser and patted dry with 4 by 4 gauze; V6 allowed R55 to roll back on to the incontinence brief with the cleansed wound touching the incontinence brief; prepared R55's medication and dressing (Peptospermum Honey and Hydrocolloid), rolled R55 back on to R55's left side; applied the medication and dressing (Peptospermum Honey and Hydrocolloid) leptospermum to the wound; assisted R55 back on to incontinence brief; and then pulled up the front of the R55's incontinence brief. At 11:10 a.m., V6 confirmed after cleansing R55's pressure wound, R55 should not have allowed R55 to roll back over resulting in the cleansed wound touching the incontinence brief which was on R55 prior to and during R55's wound care.
145720
Page 2 of 4
145720
05/03/2024
St Clara's Rehab & Senior Care
1450 Castle Manor Drive Lincoln, IL 62656
F 0758
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review the facility failed to identify target behaviors to warrant the use of an antipsychotic medication, failed to ensure a resident received the lowest effective dose of psychotropic medication (R17), and failed to ensure PRN (as needed) psychotropic medication had a 14 day stop date (R295) for two of six residents (R17 and R295) reviewed for unnecessary medications in the sample of 39.
Findings include: 1. The facility's Psychotropic Medication Policy revised 11/28/17 states, Intent: Residents are free from unnecessary psychotropic medication use. These medications are to be given to treat a specific condition/medical symptom that is diagnosed and documented in the clinical record. Specific condition/medical symptoms alone are not enough to justify pharmacological use. B. Dose, Duration, Monitoring: 1. Evaluation of pharmacological ongoing effectiveness towards therapeutic goal. 2. Evaluation of the effectiveness of the non-pharmacological approaches prior to medication administration. 3. Quarterly evaluation or more frequent if needed to determine if a reduction is warranted. C. Gradual Dose Reduction: 1. Residents should receive the lowest effective dose of psychotropic medication for the residents' physical, mental, and psychosocial well-being. The Policy also documents Initial PRN (as needed) order of antipsychotic medication should not exceed 14 days. A new order must be obtained after the physician or prescribing practitioner believes that to extend beyond the 14 days and has documented to rationale and indicated the rationale. R17's Face Sheet documents R17 admitted to the facility on [DATE] with diagnoses to include but not limited to: Unspecified Dementia with Psychotic Disturbance; Anxiety Disorder, and Depression. R17's current Care Plan documents R17 takes an antipsychotic medication related to psychosis. This same Care Plan does not document R17's specific behaviors related to R17's antipsychotic use. R17's Note to Attending Physician/Prescriber dated 2/7/24 documents a pharmacy recommendation to decrease R17's Seroquel Antipsychotic medication from 50 mg to 25 mg in an effort for a dose reduction. This same note documents V5 (R17's Physician) signed and agreed with the recommendation. R17's Physician Order Sheet dated July 2023-May 2024 documents orders for Seroquel (Antipsychotic) 25-50 milligrams/mg by mouth at bedtime for unspecified Psychosis with R17 currently receiving 50 mg by mouth at bedtime. R17's Medication Administration Records (MAR) dated February 2024 documents between 2/1/24 and 2/22/24 R17 received Seroquel 50 mg by mouth nightly. This same MAR dated 2/23/24-2/29/24 documents R17 received Seroquel 25 mg by mouth nightly. The MAR for the entire month of February 2024 documents NO behaviors exhibited by R17 were observed. R17's MAR dated March 2024 documents between 3/1/24 and 3/26/24 R17 received Seroquel 25 mg by mouth nightly. This same MAR documents between 3/27/24-3/31/24 R17 received Seroquel 50 mg by mouth nightly. The MAR for the entire month of March 2024 documents NO behaviors exhibited by R17 were observed.
145720
Page 3 of 4
145720
05/03/2024
St Clara's Rehab & Senior Care
1450 Castle Manor Drive Lincoln, IL 62656
F 0758
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Few
R17's MAR dated 4/1/24-4/30/24 documents R17 received Seroquel 50 mg by mouth nightly for the entire month. This same MAR documents NO behaviors exhibited by R17 were observed. R17's Behavior Tracking Logs dated 12/30/23-5/1/24 documents No Behaviors Observed for this period. On 4/30/24 at 11:10 AM, R17 was sitting up in a chair in R17's bedroom. R17 was calm, alert, oriented and able to answer questions well. R17 stated R17 could not recall why R17 was on the antipsychotic medication Seroquel. R17 stated, I think I was angry when I first came in, so they put me on Seroquel. I have Dementia too. That might also be why. Around 12:30 this same day, R17 was observed ambulating independently throughout the facility, socializing, and interacting with other residents well. No abnormal behaviors were observed. On 5/2/24 at 8:52 AM, V4 (Licensed Practical Nurse) stated that R17's Seroquel dose was decreased from 50 mg to 25 mg in February 2024 in response to V5's (R17's Physician) physician response to a Pharmacy Recommendation. V4 stated R17's Seroquel dose was increased back to 50 mg from 25 mg because R17 and V11 (R17's Power of Attorney) refused the reduction. V4 denied that R17 exhibited behaviors to justify the medication dose increase. On 5/1/24 at 3:14 PM, V7 (Regional Director of Operations) verified R17's behavior tracking logs were not specific to R17's behaviors for antipsychotic use and verified R17's behavior logs did not document any behaviors to warrant the use of R17's antipsychotic medication. V7 stated psychotropic medications cannot be increased for family preference if there are no associated behaviors. On 5/1/24 at 3:20 PM, V1 (Assistant Administrator) denied that R17 exhibits any behaviors to justify the use of an antipsychotic medication. 2. R295's Electronic Medical Record (EMR) document R295's diagnosis to include: Unspecified Dementia; Gastro-Esophageal Reflux Disease, Anxiety Disorder, Hallucinations, and Hypertension. R295's EMR document Physician's Order, dated 4/10/24, Lorazepam Oral Tablet 0.5 MG (milligrams). Give 1 tablet by mouth every 6 hours as needed for Anxiety. indefinite. On 5/2/24, at 11:55 a.m., V8/Regional Nurse Consultant confirmed the PRN medication should have had a 14-day stop date.
145720
Page 4 of 4